Sylvester Comprehensive Cancer Center, University of Miami | Strategic Alliance Partners

August 19, 2020

Gina Z. D'Amato, MD, discusses the utility of next-generation sequencing in patients with stage I, II, or III sarcoma.

August 07, 2020

Jonathan C. Trent, MD, PhD, discusses the role of circulating tumor DNA in soft tissue sarcoma. 

May 27, 2020

Gilberto de Lima Lopes, MD, discusses the appropriate duration of immunotherapy in lung cancer, treatment-related adverse events, and remaining challenges faced in the space.

May 21, 2020

Gilberto De Lima Lopes, MD, discusses the rationale to stop immunotherapy after 2 years in patients with lung cancer.

May 20, 2020

Gilberto De Lima Lopes, MD, discusses the rationale to stop immunotherapy after 2 years in patients with lung cancer.

May 20, 2020

Brian M. Slomovitz, MD, explaines the need to determine optimal sequencing strategies in endometrial cancer.

May 20, 2020

Brian M. Slomovitz, MD, explaines the need to determine optimal sequencing strategies in endometrial cancer.

May 01, 2020

Jonathan C. Trent, MD, PhD, discusses research efforts in bone and soft tissue sarcomas.

April 29, 2020

Gina Z. D'Amato, MD, discusses the evolution of treatment in sarcoma, the use of next-generation sequencing, and predictive and prognostic biomarkers under investigation in the space.

April 28, 2020

Terrence J. Bradley, MD, discusses the utility of ruxolitinib (Jakafi) in myelofibrosis and polycythemia vera.

April 25, 2020

Terrence J. Bradley, MD, discusses the challenges of treating patients with myeloproliferative neoplasms.

April 24, 2020

Gilberto De Lima Lopes, MD, discusses how he navigates challenges caused by COVID-19 to continue to provide optimal care to his patients with cancer.

April 17, 2020

Terrence J. Bradley, MD, discusses the evolution of therapeutic strategies in myeloproliferative neoplasms.

April 11, 2020

Gina Z. D'Amato, MD, discusses the emerging role of next-generation sequencing in sarcoma.

April 01, 2020

Richa Dawar, MD, discusses challenges with the use of neratinib in patients with metastatic HER2-positive breast cancer.

March 25, 2020

Atif Hussein, MD, and A. Craig Lockhart, MD, MHS, discuss the role of targeted therapy in colorectal and pancreatic cancer, the utility of regorafenib (Stivarga) and TAS-102 (trifluridine/tipiracil; Lonsurf) alone and in combination, and the importance of conducting next-generation sequencing.

March 17, 2020

Jonathan C. Trent, MD, PhD, discusses recent advances and ongoing research in the field of soft tissue sarcoma.

March 12, 2020

Elisa Krill-Jackson, MD, discusses the potential future utility of fam-trastuzumab deruxtecan-nxki in the treatment of patients with metastatic breast cancer.

February 18, 2020

A. Craig Lockhart, MD, MHS, professor and associate director for Regional and Strategic Clinical Research Affiliations, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses dual-immunotherapy strategies in colorectal cancer (CRC).

January 17, 2020

Matthew P. Schlumbrecht, MD, discusses the treatment of women with uterine leiomyosarcoma.